Insights

Strategic focus Private biotech specialized in metal coordination chemistry to enhance drug absorption, signaling potential for partnerships around formulation enhancement and patentable drug candidates.

Partnership potential Recent collaboration with RS BioTherapeutics and Marshall University on RSBT-001 indicates openness to co-development and academic-industrial partnerships to advance early-stage projects.

Clinical leverage Targeting drugs with short half-lives like liothyronine and levodopa; opportunities exist to position Synthonics as a partner for extending half-life and improving bioavailability in existing therapies.

Financial profile Revenue in the low-mid tens of millions with modest funding; potential for growth through licensing deals, milestone-driven collaborations, or to support scaled pilot studies.

Market readiness Small-to-mid size team (11-50 employees) suggests agility for strategic partnerships with faster decision cycles; identify niche pharma/biotech players seeking next-generation formulations and faster time-to-market.

Similar companies to Synthonics, Inc.

Synthonics, Inc. Tech Stack

Synthonics, Inc. uses 8 technology products and services including WordPress, Mailchimp, Microsoft 365, and more. Explore Synthonics, Inc.'s tech stack below.

  • Content Management System
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Nginx
    Web Servers

Synthonics, Inc.'s Email Address Formats

Synthonics, Inc. uses at least 1 email format:
Synthonics, Inc. Email FormatsExamplePercentage
FLast@synthonicsinc.comJDoe@synthonicsinc.com
100%

Frequently Asked Questions

What is Synthonics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Synthonics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Synthonics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Synthonics, Inc.'s official website is synthonicsinc.com and has social profiles on LinkedIn.

How much revenue does Synthonics, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, Synthonics, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Synthonics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Synthonics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Synthonics, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, Synthonics, Inc. has approximately 11 employees across 1 continents, including North America. Key team members include President: T. P. and General Counsel: D. B. Explore Synthonics, Inc.'s employee directory with LeadIQ.

What industry does Synthonics, Inc. belong to?

Minus sign iconPlus sign icon
Synthonics, Inc. operates in the Biotechnology Research industry.

What technology does Synthonics, Inc. use?

Minus sign iconPlus sign icon
Synthonics, Inc.'s tech stack includes WordPress, Mailchimp, Microsoft 365, jQuery, jQuery Migrate, X-Content-Type-Options, Google Analytics and Nginx.

What is Synthonics, Inc.'s email format?

Minus sign iconPlus sign icon
Synthonics, Inc.'s email format typically follows the pattern of FLast@synthonicsinc.com. Find more Synthonics, Inc. email formats with LeadIQ.

How much funding has Synthonics, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, Synthonics, Inc. has raised $3.1M in funding. The last funding round occurred on Aug 05, 2014.

When was Synthonics, Inc. founded?

Minus sign iconPlus sign icon
Synthonics, Inc. was founded in 2006.
Synthonics, Inc. logo

Synthonics, Inc.

Biotechnology ResearchVirginia, United States11-50 Employees

Synthonics, Inc. is a privately held biotechnology research company focused on developing patentable drug candidates that leverage its proprietary metal coordination chemistry to improve absorption and therapeutic effect. By binding metals to established pharmaceutical agents, the firm aims to create products with enhanced clinical utility, particularly for drugs with short half-lives such as T3 (liothyronine) and levodopa. The company serves the pharmaceutical and biomedical research sectors, addressing the challenge of limited bioavailability in certain medications. Based in Blacksburg, Virginia, the organization operates within the biotechnology research industry and has a presence as a small to mid-sized specialized player. A recent development includes a collaboration with RS BioTherapeutics, announced in 2022, that involved joint work with Synthonics and Marshall University on a proof-of-concept study for RSBT-001.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $3.1M

    Synthonics, Inc. has raised a total of $3.1M of funding over 2 rounds. Their latest funding round was raised on Aug 05, 2014 as a Venture Round.

  • $10M - $25M

    Synthonics, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.